ConferenceSeries

International Conferences

Meet Inspiring Speakers and Experts at our 3000+ Global Conference Series Events with over 1000+ Conferences, 1000+ Symposiums
and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series : World's leading Event Organizer

 

Rosie Tilli

Nursing student in Australian Catholic University, Australia

Title: PSSD (Post SSRI Sexual Dysfunction)

Biography

Rosie is a 22 year old nursing student in Australian Catholic University, Melbourne, Australia. My life was full of hopes and dreams until I took Escitalopram in August 2020 - December 2020. Ever since then, PSSD changed my life in the worst way imaginable

Abstract

PSSD is an iatrogenic syndrome which stands for Post SSRI Sexual Dysfunction. It’s important to note that this is not the same as SSRI-induced sexual dysfunction, as the condition is referring to symptoms occurring after discontinuation of the offending drug.

It can occur from all types of anti-depressants such as SSRI’s SNRI’s, tricyclics and atypical antidepressants.

The name PSSD is a misnomer, because it doesn’t highlight the debilitating cognitive and emotional impairment experienced by patients.

Symptoms are usually seen in 4 different categories which are sexual, physical (nonsexual), emotional, and cognitive. Symptoms vary between patients from mild to extreme. Some of the key symptoms across these categories include sexual dysfunction: complete loss of libido, anorgasmia, weak orgasms, genital numbness, genital pain, and inability to experience pleasure during sex, emotional blunting (an inability to physically feel positive emotions) and cognitive impairment.

A diagnosis of PSSD is tricky, as it is currently not a medically “recognised” condition. However PSSD can be diagnosed when a person has passed the 3 month mark since discontinuing their medication, and is still experiencing side effects.

These side effects are typically debilitating, and cause a high amount of psychological and sexual distress for sufferers. As well as this, symptoms persist indefinitely. Symptoms may reduce and patients can make a full recovery, or symptoms can progressively get worse leaving patients stuck for decades.

There are other drugs that can cause these symptoms, including isotretinoin (and other retinoids), and propecia.

It’s important for prescribers to be aware of PSSD to avoid re-instating medications that generated PSSD in the first place. Re- instatement is dangerous as it can permanently worsen symptoms. Unfortunately research in this area is limited, and we still don’t know the underlying pathophysiological mechanisms driving PSSD, nor any helpful treatments.

 

 

Conference Series Destinations

Contact Us

Medical Conferences
Jessie Grace
[email protected]
1-702-508-5200 Ext:8031, 8041

Pharmaceutical Conferences
Badoni Victor
[email protected]
1-702-508-5200 Ext:8045, 8047

Immunology & Microbiology Conferences
Walker Smith
[email protected]
1-702-508-5200 Ext:8031

Cancer Conferences
Raul Cliff
[email protected]
1-702-508-5200 Ext:8039

Nursing and Healthcare Conferences
Jennifer Leny
[email protected]
1-702-508-5200 Ext:8044

Diabetes Conferences
Stanley knight
[email protected]
1-702-508-5200 Ext:8040

Neuroscience Conferences
Sandeep Kumar
[email protected]
1-702-508-5200 Ext:8034

Dental Conferences
Raul Cliff
[email protected]
1-702-508-5200 Ext:8039

Clinical and Biochemistry Conferences
Rohit Casper
[email protected]
1-702-508-5200 Ext:8033

Biotechnology Conferences
Ravi Vittal
[email protected]
1-702-508-5200 Ext:8031, 8037

Material Science Conferences
Lucy Grey
[email protected]
1-702-508-5200 Ext:8035

Genetics & Mol Biology Conferences
Stephen Bruce
[email protected]
1-702-508-5200 Ext:8038

Engineering Conferences
Dolly A
[email protected]
+1-702-508-5200 Ext:8051

Program Enquiries
Symposia/Workshops
Sponsorships
Media Partners | Advertising